Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Muscle Nerve. 2019 Jan 11;59(5):537–543. doi: 10.1002/mus.26397

Table 3.

Logistic regression model showing the associations between clinical factors and SAMS.

(SAMS group: n=549; statin-tolerant group: n=99)

Variables Odds Ratio (95% CI)
Family history of heart disease* 3.60 (2.08, 6.22)
Hypertension* 2.24 (1.33, 3.77)
Obesity* 3.08 (1.18, 8.05)
History of smoking* 2.08 (1.16, 3.74)
Rosuvastatin vs Atorvastatin 2.69 (1.00, 7.24)
Simvastatin vs Atorvastatin 2.42 (1.18, 4.97)
Rosuvastatin vs Simvastatin 1.11 (0.35, 3.49)
*

compared to no family history, no hypertension, no obesity, or no smoking history.

SAMS: statin-associated muscle symptoms